Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical significance of Philadelphia-like-related genes in a resource-constrained setting of adult B-acute lymphoblastic leukemia patients.
Lima K, Rojas CAO, Nogueira FL, da Silva WF, Cavaglieri RC, Nardinelli L, Leal AM, Velloso EDRP, Bendit I, Alencar A, Mullighan CG, Machado-Neto JA, Rego EM. Lima K, et al. Among authors: bendit i. EJHaem. 2024 Oct 7;5(6):1366-1369. doi: 10.1002/jha2.1030. eCollection 2024 Dec. EJHaem. 2024. PMID: 39691248 Free PMC article. No abstract available.
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
Lipreri da Silva JC, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WFD, Velloso EDRP, Bendit I, Costa-Lotufo LV, Rego EM, Ridley AJ, Machado-Neto JA. Lipreri da Silva JC, et al. Among authors: bendit i. Eur J Pharmacol. 2025 Jan 15;987:177161. doi: 10.1016/j.ejphar.2024.177161. Epub 2024 Nov 29. Eur J Pharmacol. 2025. PMID: 39615869
Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia.
Salustiano-Bandeira ML, Moreira-Aguiar A, Pereira-Martins DA, Coelho-Silva JL, Weinhäuser I, França-Neto PL, Lima AS, Lima AS, Baccarin AR, Silva FB, de Melo MA, Niemann FS, Nardinelli L, Ortiz Rojas CA, Duarte BK, Araujo AS, Azevedo EA, Morais CN, Figueiredo-Pontes LL, Schuringa JJ, Huls G, Bendit I, Rego EM, Olalla Saad ST, Traina F, Bezerra MA, Lucena-Araujo AR. Salustiano-Bandeira ML, et al. Among authors: bendit i. Blood Cancer J. 2024 Jun 24;14(1):102. doi: 10.1038/s41408-024-01086-8. Blood Cancer J. 2024. PMID: 38914584 Free PMC article. No abstract available.
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K, Nogueira FL, Cipelli M, Carvalho MFL, Pereira-Martins DA, da Silva WF, Cavaglieri RC, Nardinelli L, Leal AM, Velloso EDRP, Bendit I, Câmara NOS, Schuringa JJ, Machado-Neto JA, Rego EM. Lima K, et al. Among authors: bendit i. Eur J Pharmacol. 2024 Aug 15;977:176723. doi: 10.1016/j.ejphar.2024.176723. Epub 2024 Jun 6. Eur J Pharmacol. 2024. PMID: 38851560
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Ferreira MPS, Rego EM, Rocha V, Bendit I. Ferreira APS, et al. Among authors: bendit i. Ann Hematol. 2023 Jul;102(7):1969. doi: 10.1007/s00277-023-05242-1. Ann Hematol. 2023. PMID: 37160499 Free PMC article. No abstract available.
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response.
Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Ferreira MPS, Rego EM, Rocha V, Bendit I. Ferreira APS, et al. Among authors: bendit i. Ann Hematol. 2023 Jul;102(7):1761-1771. doi: 10.1007/s00277-023-05189-3. Epub 2023 Apr 13. Ann Hematol. 2023. PMID: 37052662 Free PMC article.
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA, Barreto GC, Culler HF, Cavalcante JB, de Oliveira Alves LB, Nardinelli L, Bendit I, Zerbini MCN, Rocha V, Pereira J. de Pádua Covas Lage LA, et al. Among authors: bendit i. Cancer Biomark. 2022;35(2):179-191. doi: 10.3233/CBM-220013. Cancer Biomark. 2022. PMID: 36093687
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice.
Boquimpani C, Seguro FS, Magalhães GHR, Pinto ILS, Bendit I, Bortolini JAP, Pagnano KBB, Centrone R, Funke V. Boquimpani C, et al. Among authors: bendit i. Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):402-409. doi: 10.1016/j.htct.2022.04.002. Epub 2022 May 3. Hematol Transfus Cell Ther. 2022. PMID: 35654721 Free PMC article. Review.
85 results